Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 135

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 135
---
, governmental bodies or other business relationships;                                                                                                                                                                            |

-80-

| (ix) | any event, occurrence, circumstance, change, or effect arising directly or indirectly from or otherwise                                                                                                                
 relating to any change in, or any compliance with or action taken for the purpose of complying with any change in, any legal requirement or GAAP (or interpretations or enforcement of any legal requirement or GAAP); |

| (x) | any event, occurrence, circumstance, change or effect resulting or arising from any actual or potential                                                             
 sequester, stoppage, shutdown, default, or similar event or occurrence by or involving any governmental body affecting a national or federal government as a whole; |

| (xi) | any event, occurrence, circumstance, change or effect resulting or arising from changes in anti-dumping 
 actions, international tariffs, trade policies, sanctions, legal requirements, or any “trade wars”;     |

| (xii) | any event, occurrence, circumstance, change or effect resulting or arising from any stockholder litigation; |

| (xiii) | any event, occurrence, circumstance, change or effect resulting or arising from any breach by Alcon or Merger 
 Sub of the Merger Agreement; or                                                                               |

| (xiv) | any event, occurrence, circumstance, change or effect resulting or arising from certain specific matters in the 
 confidential disclosure schedule;                                                                               |

providedthat if any event, occurrence, circumstance, change or effect set forth in clauses (iii), (iv), (v), (ix), (x) and (xi) above has had, or would reasonably be expected to have, a disproportionate and adverse effect on STAAR and its subsidiaries, taken as a whole, relative to other medical device companies in similar geographies in STAAR and its subsidiaries they operate, then only the incremental disproportionate adverse effect may be taken into account in determining whether a Material Adverse Effect with respect to STAAR has occurred. In the Merger Agreement, STAAR has made customary representations and warranties to Alcon and Merger Sub that are subject, in some cases, to specified exceptions and qualifications contained in the Merger Agreement and the confidential disclosure schedule. These representations and warranties relate to, among other things:

| • |     | due organization, valid existence, good standing, and authority and qualification to conduct business with 
 respect to STAAR and its subsidiaries;                                                                     |

| • |     | the certificate of incorporation and bylaws of STAAR and its subsidiaries; |

| • |     | ownership and capital